keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 152.00 | |
10 mg | Inquiry | $ 255.00 | |
25 mg | Inquiry | $ 461.00 | |
50 mg | Inquiry | $ 875.00 | |
100 mg | Inquiry | $ 1,496.00 | |
200 mg | Inquiry | $ 2,323.00 |
Description | Cenupatide is a urokinase plasminogen activator receptor (uPAR) inhibitor. Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of STZ-induced diabetes. Cenupatide reverted STZ-induced up-regulation of uPA levels and activity, while uPAR on podocytes and (s)uPAR were unaffected. In glomeruli, Cenupatide inhibited FPR2 expression. |
Synonyms | UPARANT, Cenupatide trifluoroacetic acid salt, Ac-Arg-Aib-Arg-α(Me)Phe-NH2) |
Molecular Weight | 617.756 |
Formula | C28H47N11O5 |
CAS No. | 1006388-38-0 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cenupatide 1006388-38-0 Ac-Arg-Aib-Arg-alpha(Me)Phe-NH2) Cenupatide trifluoroacetic acid UPARANT Cenupatide trifluoroacetic acid salt Ac-Arg-Aib-Arg-a(Me)Phe-NH2) Ac-Arg-Aib-Arg-α(Me)Phe-NH2) inhibitor inhibit